110 related articles for article (PubMed ID: 3294401)
21. Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
Gaviraghi G; Perboni A; Tamburini B; Xerri L; Salvatori A; Spadoni G; Tarzia G
Farmaco; 1996 Jul; 51(7):535-8. PubMed ID: 8765676
[TBL] [Abstract][Full Text] [Related]
22. [Beta-lactamase inhibitors and their possible therapeutic significance].
Fomina IP; Lobuseva AN; Navashin SM
Antibiotiki; 1984 Feb; 29(2):142-8. PubMed ID: 6367631
[No Abstract] [Full Text] [Related]
23. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
[TBL] [Abstract][Full Text] [Related]
24. Emerging trends in antimicrobial resistance in surgical infections. A review.
Neu HC
Eur J Surg Suppl; 1994; (573):7-18. PubMed ID: 7524800
[TBL] [Abstract][Full Text] [Related]
25. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
Pal RB; Pal P; Jain S; Kulkarni KP
J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
[TBL] [Abstract][Full Text] [Related]
26. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
27. [Activity of ticarcillin combined with different concentrations of clavulanic acid on 137 Gram-negative bacilli resistant to ticarcillin].
Aubert G; Dorche G; Frere A; Raby N; Denis M
Pathol Biol (Paris); 1987 May; 35(5):537-41. PubMed ID: 3302858
[TBL] [Abstract][Full Text] [Related]
28. A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance.
Neu HC; Chin NX
Chemioterapia; 1985 Feb; 4(1):63-70. PubMed ID: 3872725
[TBL] [Abstract][Full Text] [Related]
29. Timentin (ticarcillin/clavulanic acid): lack of antagonism in an in vitro kinetic model, against bacteria producing inducible class-1 beta-lactamase.
Slocombe B; Cooper CE; Masters PJ; Warrack JD
J Chemother; 1989 Jul; 1(4 Suppl):353-4. PubMed ID: 16312436
[No Abstract] [Full Text] [Related]
30. [Progress in chemotherapeutic agents--beta-lactam antibiotics and beta-lactamase inhibitors].
Uzuka Y; Matsumoto K
Nihon Rinsho; 1986 Apr; 44(4):824-30. PubMed ID: 3531574
[No Abstract] [Full Text] [Related]
31. Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.
Neu HC
Am J Med; 1985 Nov; 79(5B):2-12. PubMed ID: 3907341
[TBL] [Abstract][Full Text] [Related]
32. Overcoming Beta-Lactamase-Based Antimicrobial Resistance by Nanocarrier-Loaded Clavulanic Acid and Antibiotic Cotreatments.
Filby BW; Weldrick PJ; Paunov VN
ACS Appl Bio Mater; 2022 Aug; 5(8):3826-3840. PubMed ID: 35819369
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic usage in pelvic infections. An overview.
Faro S
J Reprod Med; 1988 Jun; 33(6 Suppl):566-70. PubMed ID: 3294400
[TBL] [Abstract][Full Text] [Related]
34. Classification of beta-lactamase-producing bacteria.
Sutherland R
Scott Med J; 1982; 27 Spec No.():S3-9. PubMed ID: 6984779
[TBL] [Abstract][Full Text] [Related]
35. Beta-lactamases, beta-lactamase inhibitors, and skin and skin-structure infections.
Neu HC
J Am Acad Dermatol; 1990 May; 22(5 Pt 1):896-904. PubMed ID: 2189913
[TBL] [Abstract][Full Text] [Related]
36. Beta-lactamase inhibition: therapeutic implications in infectious diseases--an overview.
Moellering RC
Rev Infect Dis; 1991; 13 Suppl 9():S723-6. PubMed ID: 1925316
[No Abstract] [Full Text] [Related]
37. Inhibition of beta-lactamase by 1,4-naphthalenedione from the plant Holoptelea integrifolia.
Vinod NV; Shijina R; Dileep KV; Sadasivan C
Appl Biochem Biotechnol; 2010 Mar; 160(6):1752-9. PubMed ID: 19424669
[TBL] [Abstract][Full Text] [Related]
38. N-pyrrylderivatives of penicillins. Kinetics and inhibition studies with clavulanic acid of a Bacillus cereus beta-lactamase.
Díez MT; Arín MJ; Negro A; Salto F
Pharmazie; 1987 Jun; 42(6):415-6. PubMed ID: 3118398
[No Abstract] [Full Text] [Related]
39. The role of beta-lactamase-producing bacteria in obstetrical and gynecological infections.
Brook I
Gynecol Obstet Invest; 1991; 32(1):44-50. PubMed ID: 1765319
[TBL] [Abstract][Full Text] [Related]
40. Clinical application of the newer beta-lactam antibiotics.
Turck M
J Antimicrob Chemother; 1988 Jul; 22 Suppl A():45-62. PubMed ID: 3062004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
